Peer-influenced content. Sources you trust. No registration required. This is HCN.
Journal of the American College of Cardiology (JACC)
A network meta-analysis of 24 trials (16,371 patients) found complete revascularization in myocardial infarction with multivessel disease reduced all-cause mortality by 15% compared to culprit-only revascularization, suggesting potential improved outcomes for this population.
Cardiology July 22nd 2024
Cleveland Clinic Journal of Medicine
SGLT-2 inhibitors offer benefits beyond glucose control, potentially addressing the systemic inflammatory components of metabolic diseases like diabetes, heart failure, and gout.
MDLinx
A remarkable case of a four-year-old boy surviving a 19-hour cardiac arrest with no medical explanation of why his heart starting beating again.
Cardiology July 9th 2024
Healthgrades for Professionals
Recent survey findings reveal that nearly one-third of adults aged 60 and older take daily aspirin for primary prevention of heart disease, despite updated guidelines advising against it for those without prior cardiovascular events.
Northwestern Medicine
Pulmonary thromboendarterectomy (PTE) offers significant symptom improvement for over 75% of CTEPH patients. Specialized care centers are critical for successful outcomes due to the complexity of the procedure.
The New England Journal of Medicine
AL amyloidosis presents a diagnostic challenge due to its varied symptoms, but advancements in therapeutic options, including CyBorD plus daratumumab and emerging antifibril monoclonal antibodies, offer hope for better patient management.